scispace - formally typeset
G

Giovanni B. Frisoni

Researcher at University of Geneva

Publications -  956
Citations -  55940

Giovanni B. Frisoni is an academic researcher from University of Geneva. The author has contributed to research in topics: Dementia & Medicine. The author has an hindex of 101, co-authored 871 publications receiving 46199 citations. Previous affiliations of Giovanni B. Frisoni include Geneva College & University of Rome Tor Vergata.

Papers
More filters
Journal ArticleDOI

Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota.

TL;DR: This work sequenced bacterial 16S rRNA from fecal samples of Aβ precursor protein (APP) transgenic mouse model and found a remarkable shift in the gut microbiota as compared to non-transgenic wild-type mice, indicating a microbial involvement in the development of Abeta amyloid pathology and suggesting that microbiota may contribute to the developed neurodegenerative diseases.
Journal ArticleDOI

Resting state fMRI in Alzheimer's disease: beyond the default mode network.

TL;DR: The results suggest that AD is associated with an alteration of large-scale functional brain networks, which extends well beyond the DMN, which may be paralleled, in an attempt to maintain cognitive efficiency, by an increased prefrontal connectivity.
Journal ArticleDOI

Brain atrophy in Alzheimer's Disease and aging.

TL;DR: A comprehensive overview of the main findings in AD and normal aging over the past twenty years, focusing on the patterns of gray and white matter changes assessed in vivo using MRI.
Journal ArticleDOI

Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis

Jonathan D. Rohrer, +63 more
- 01 Mar 2015 - 
TL;DR: Structural imaging and cognitive changes can be identified 5-10 years before expected onset of symptoms in asymptomatic adults at risk of genetic frontotemporal dementia, which could help to define biomarkers that can stage presymPTomatic disease and track disease progression.